Why did Instacart (CART) stock rally almost 10% in a day?

Adagene Eyes Phase II Data for Masked CTLA-4 Therapy in MSS Colorectal Cancer

If You Invest $1,000 a Year in Morgan Stanley (MS) Stock, How Much Dividend Income Could It Generate Over 20 Years?

Home Depot IT chief says its digital price tags won't give consumers different prices

History Shows 1 Powerful Fact That Makes Me Bullish on VTI

Berkshire Hathaway Stock Rose 10 Days in a Row in October for the First Time Since 2018. Here's What History Says Comes Next.

Enova: Growing 33% Without A Bank, Still Trades At 10x Earnings (Buy)

Where Will Bloom Energy Stock Be in 5 Years?

Why Carpenter Technology Stock Plunged 24.5% This Week

Employees group warns of major Swiss job losses if UBS relocates, newspaper says

Here's the Price at Which I'd Buy Microsoft Stock

Libtayo® (cemiplimab) Longer-Term Data Show Increasing and Clinically Meaningful Overall Survival Benefit with Adjuvant Treatment in High-Risk Cutaneous Squamous Cell Carcinoma (CSCC)

Columbia Banking System: Massive Share Repurchase And A 5% Yield

Elon Musk Wants to Give Every American Child a Share of SpaceX. Here's What It Would Cost -- and What It Means for Everyone Else Holding the Stock

Your Social Security COLA Notice Arrives in December. Here's How to Estimate Your 2027 Raise Before Then.

Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors

Ocular Therapeutix: The Drug Won, The Stock Lost, And That's The Opportunity

Nvidia vs. Micron: The AI Revolution Is Big Enough for Both. Here's the Better Buy.

Amgen vs. Gilead Sciences: Which Biotech Dividend Stock Is the Better Buy?

Prediction: This Is Where Palantir Stock Will Trade When Its Revenue Hits $10 Billion

Can Independent Venues Survive the Rise of Live Nation?

Prediction: Amazon Stock Will Skyrocket After Oct. 29 Thanks to AWS Growth

President Donald Trump Just Proclaimed, "Tariffs Don't Cause Inflation, They Cause Wealth," but Data From Federal Reserve Economists Show Otherwise

Alphabet's 2 Classes of Common Stock Trade About 1% Apart. Here's the One I'd Buy.

BioNTech and Bristol Myers Squibb Report Encouraging Global Phase 2 Data for Pumitamig in Advanced NSCLC After Progression on Immunotherapy Plus Chemotherapy

SpaceX Just Shared Great News for Artificial Intelligence (AI) Investors. Here Are 2 Stocks That Could Benefit

Capstone Energy+ Eyes Data Centers With ‘Energy Certainty' Push

Vicor: Don't Get Off This Ride

Avalo Therapeutics: Contrarian 'Buy' Ahead Of Abdakibart's Phase 3

Palvella Therapeutics Eyes QTORIN Launch as Rare-Disease Pipeline Expands

Got $1,000? This Nuclear Fuel Stock Is the Pick-and-Shovel Play I'd Buy Right Now.

GM Just Announced a $20 Billion Buyback. Tesla Trades at 350 Times Earnings.

Spotify Earnings: A Miss, But Long-Term Potential Remains

Meet the Ultra-High-Yield Dividend Stock That Has Doubled the S&P 500's Returns This Year

Warren Buffett Won His 10-Year Bet Against Hedge Funds. Here's What the S&P 500 Has Done Since It Ended.

TRX Gold: Buckreef Continues Well, As Both Engine And Growth Path

OmniAb Highlights $3B Milestone Pipeline, AI Antibody Platform at Conference

Prospera Energy Announces Service Rig Update as Luseland Workovers Come Online at 3.3x Prior Rates

Protagonist Therapeutics: The Opt-Out That Turned A Biotech Into A Royalty Compounder

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Triller Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ILLR

FitLife Brands Eyes Acquisitions, Margin Gains to Offset Organic Growth Headwinds

Should Investors Buy the Meta Platforms Dip?

Constellation, Vistra, and GE Vernova Ranked From Worst to First for the AI Power Boom

Strawberry Fields REIT CEO Maps SNF Growth Strategy, 100% Rent Collection Record

Bloom Energy: Strong Results Not Sufficient To Overcome Deteriorating Big Picture

IDEX Corporation Is Growing Nicely, But Not Enough To Justify A Bullish Rating

Rocket Lab Just Postponed Its Neutron Launch. Again.

YSS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages York Space Systems Inc. Investors to Secure Counsel Before Important October 30 Deadline in Securities Class Action - YSS

IVES: Dan Ives' Top Picks Are Strong, And Surprisingly Cheap

Flotek Deadline: FTK Investors Have Opportunity to Lead Flotek Industries, Inc. Securities Fraud Lawsuit

Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting

Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting

Is Now a Good Time to Buy Lockheed Martin?

CELH IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Celsius Holdings, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - CELH

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Millrose Properties, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRP

FDN: Mixed Performance, Factor Disadvantages, Welcome A Skeptical View

1 Red Flag That Keeps Me From Buying AMD Stock

VYMI: High Yield, Strong Dividend Growth, And Now A Buy (Upgrade)

Profit From Wider Credit Spreads With SPHY

Is the AI Bubble About to Burst? Plus, Apple Bets on Doorbells.

SpaceX's $1 Trillion Revenue Ambition: Can Elon Musk Deliver?

2 Warren Buffett Artificial Intelligence (AI) Stocks I'd Buy Right Now and Never Sell

Should You Ignore the SpaceX Hype and Buy Rocket Lab Instead?

Flying Cars, Smart Homes, and Cracks in the AI Boom

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Gildan Activewear Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - GIL

Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026

Can Hyperliquid (HYPE) Get Back to $90 by the End of 2026?

UPS Stock Is Down 57% From Its Record. Is It a Buy Before Its Oct. 27 Report?

GIL Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Gildan Activewear Inc. Class Action Lawsuit

Amgen Inc. (AMGN) Presents at 2026 European Society for Medical Oncology (ESMO) Annual Congress Transcript

HYLN DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Hyliion Holdings Corp. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class Action - HYLN

FuelCell Energy, Inc. Class Action Reminder – Robbins LLP Encourages FCEL Investors to Contact the Firm for Information About Their Rights

Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study

UNCY DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - UNCY

Forget the FDA Delay: 3 Reasons Exelixis Is Still a Buy

Moderna, Inc. (MRNA) Discusses Phase III Data for Intismeran and Advances in Cancer Immunotherapy Transcript

Baidu, Inc. Class Action Reminder – Robbins LLP Encourages BIDU Investors to Contact the Firm for Information About Their Rights

Booking vs. Chewy: Do Pet Treats or Plane Tickets Make for a Better Stock in 2026?

AST SpaceMobile, Inc. Class Action Reminder - Robbins LLP Encourages ASTS Investors to Contact the Firm for Information About Their Rights

Elon Musk Says Ukraine Violated Starlink's Rules

YSS DEADLINE NOTICE: ROSEN, A LEADING NATIONAL FIRM, Encourages York Space Systems Inc. Investors to Secure Counsel Before Important October 30 Deadline in Securities Class Action – YSS

Advance Auto Parts vs. Etsy: Which Consumer Stock Is a Better Buy in 2026?

Why Is Solana Worth About 17 Times More Than Sui?

PZZA DEADLINE NOTICE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Papa John's International, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - PZZA

First Interstate BancSystem: 3 Key Takeaways for Long-Term Investors

INV IMPORTANT DEADLINE: ROSEN, A LEADING NATIONAL FIRM, Encourages Innventure, Inc. Investors to Secure Counsel Before Important October 27 Deadline in Securities Class Action - INV

Moderna Melanoma Therapy Cuts Recurrence Risk 42% in Phase 3 Trial

Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter More

Booking vs. Five Below: Is the Travel Giant or Specialty Retailer the Better Stock to Buy in 2026?

Lindt got chocolate price hikes wrong, chairman says after CEO's ouster

Netflix Stock Has Always Overcome the Odds. Has It Finally Hit a Wall?

Before You Buy the Vanguard S&P 500 ETF, There's 1 Sneaky Risk Investors Should Know

Berkshire Owns Both Chevron and Occidental. Which Oil Stock Is the Better Buy Now?

Parabilis Highlights 72% Response Rate, Maps Phase III Desmoid Trial for 2027

Here's How Many Shares of Apple Stock You'd Need for $100 in Yearly Dividends

Starlink seems to be working normally again in Ukraine

GE Vernova Stock Fell 11% in a Day. Here's What I Think It Could Be Worth by 2030.

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Better Home & Finance Holding Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - BETR

Booking vs. GameStop: Is Travel or Collectibles the Better Value Creator in Stocks?

BBNX DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important November 3 Deadline in Securities Class Action - BBNX